Navigation Links
UCLA Program Aims to Revolutionize Kidney Transplants
Date:8/19/2007

LOS ANGELES, Aug. 10 /PRNewswire-USNewswire/ -- New and innovative programs to obtain donor organs have the potential to revolutionize kidney transplantation. At UCLA, for example, transplant experts are studying a program they call "living donor swap."

This program enables the relative or friend of a kidney-transplant patient who is not compatible as a donor to "swap" organs with another potential donor who also may be an incompatible match for his or her relative or friend. This greatly broadens the pool of organs available from living donors.

"Swapping organs makes sense in such cases," says Albin Gritsch, M.D., UCLA urologist.

In the case of a "living donor swap," both transplants are done simultaneously, Dr. Gritsch explains. Advances in living-donor-transplant technology make the surgery less invasive and the pain easier to manage.

UCLA has been among the pioneers in the field of kidney transplantation, and consistently ranks among the top five centers nationally. Currently, about two-thirds of kidney transplants are performed with organs taken from deceased donors, explains UCLA nephrologist Alan Wilkinson, M.D., and the wait can often be as long as five years, making living-donor transplantation an attractive alternative. Living donors, often family or friends of the transplant patient, currently account for about one third of cases.

The door to increasing living-donor transplantation also has been opened wider with pioneering surgical techniques, including laparoscopic harvesting of donor kidneys, which results in less pain and a quicker recovery, notes Gabriel Danovitch, M.D., director of Kidney and Kidney/Pancreas Transplantation at UCLA.

To view a video about an actual living donor kidney transplant, go to http://streaming.uclahealth.org/kidney.

This news release was issued on behalf of Newswise(TM). For more information, visit

SOURCE University of California, Los Angeles (UCLA), Health
Sciences

Copyright©2007 PR Newswire.

0

GOOD

Page: 1 2

Related medicine technology :

1. Inspiration Biopharmaceuticals Presents Data From Hemophilia Program at International Society On Thrombosis and Haemostasis (ISTH) Annual Meeting
2. Pieris Progresses Proprietary Asthma Program: Validation of Pulmonary Delivery of Anticalin-Based Protein Product Candidate
3. Major New Review Supports the Broader Potential of CeNeS COMT Inhibitor Discovery Programme
4. Elixir Pharmaceuticals Presents Preclinical Data Highlighting Its Ghrelin Antagonist Program at the American Diabetes Associations Annual Meeting
5. Pharmexa A/S (DK) - Pharmexa presents data from influenza program
6. Amylin Pharmaceuticals to Present New Data from Broad Diabetes and Obesity Programs at ADA 2007
7. Ambrilia Highlights Encouraging Data for its HIV Integrase Inhibitor Program and Recent Developments at Annual Meeting
8. CuraGen Presents Update on Clinical Development Program for Belinostat
9. Hana Biosciences Presents Data On Two Programs At the American Society of Clinical Oncology Annual Meeting
10. Diatos Announces Positive Clinical Results for its DTS-201 Doxorubicin Prodrug Program
11. OXiGENE Abstracts Published in ASCO Program
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/4/2009)LAKE FOREST, Ill., Dec. 4 Hospira, Inc. (NYSE: HSP ), a leading global specialty pharmaceutical and medication delivery company, today announced the launch of its next-generation 50 mL and 100 mL V
(Date:12/4/2009)HOUSTON, Dec. 4 OrthoAccel Technologies, Inc., developers of the AcceleDent System , which is an acceleration device to enhance orthodontics, announced the availability of a new Continuing Education
(Date:12/4/2009)WILMINGTON, Del., Dec. 4 AstraZeneca (NYSE: AZN ) today announced that the US Food and Drug Administration (FDA) has approved once-daily SEROQUEL XR® (quetiapine fumarate) Extended Release Tab
Breaking Medicine Technology:Hospira Expands VisIV(TM) Portfolio to Offer Complete Range of Environmentally Friendly I.V. Containers 2Hospira Expands VisIV(TM) Portfolio to Offer Complete Range of Environmentally Friendly I.V. Containers 3Hospira Expands VisIV(TM) Portfolio to Offer Complete Range of Environmentally Friendly I.V. Containers 4AcceleDent Science is Showcased in New Continuing Education Course Published by PennWell 2AcceleDent Science is Showcased in New Continuing Education Course Published by PennWell 3AcceleDent Science is Showcased in New Continuing Education Course Published by PennWell 4US FDA Approves SEROQUEL XR(R) For Add-On Treatment of Major Depressive Disorder 2US FDA Approves SEROQUEL XR(R) For Add-On Treatment of Major Depressive Disorder 3US FDA Approves SEROQUEL XR(R) For Add-On Treatment of Major Depressive Disorder 4US FDA Approves SEROQUEL XR(R) For Add-On Treatment of Major Depressive Disorder 5US FDA Approves SEROQUEL XR(R) For Add-On Treatment of Major Depressive Disorder 6US FDA Approves SEROQUEL XR(R) For Add-On Treatment of Major Depressive Disorder 7US FDA Approves SEROQUEL XR(R) For Add-On Treatment of Major Depressive Disorder 8US FDA Approves SEROQUEL XR(R) For Add-On Treatment of Major Depressive Disorder 9Sono Tek Announces Second Quarter Results 5398 1Sono Tek Announces Second Quarter Results 5398 2Sono Tek Announces Second Quarter Results 5398 3AvMed Covers H1N1 Flu Vaccine For Members 5395 1AvMed Covers H1N1 Flu Vaccine For Members 5395 2Allscripts and Sandata Partner to Enhance Quality in Home Care Agencies Nationwide 10323 1Allscripts and Sandata Partner to Enhance Quality in Home Care Agencies Nationwide 10323 2Allscripts and Sandata Partner to Enhance Quality in Home Care Agencies Nationwide 10323 3
...LVERN, Pa., Nov. 18 Arlington Medical Resources (...r the pharmaceutical and diagnostic,imaging indust... Privigen was,sold in the U.S. during the third qu...ravenous immune globulin (IVIG) and was launched i...ated from the blood plasma of thousands,of donors ...
...ndomized study will enroll newly diagnosed, elderl...Celator Pharmaceuticals today announced that the f...e 2 clinical study of CPX-351 (Cytarabine:Daunorub...agnosed acute myeloid leukemia (AML). , , The... the Weill Medical College of Cornell University ...
Other Medicine Technology:Over $10 Million of CSL Behring's Privigen Was Sold in the U.S. During the Third Quarter of 2008 2Celator(R) Pharmaceuticals Announces Enrollment of First Patient in Phase 2 Study with CPX-351 2Celator(R) Pharmaceuticals Announces Enrollment of First Patient in Phase 2 Study with CPX-351 3
(Date:12/5/2009)NEW ORLEANS, Dec. 5 Leukemia and myeloproliferative disorders are serious and often deadly blood cancers. Research presented today at the 51st Annual Meeting of the American Society of Hematology int
(Date:12/5/2009)The MAMA campaign is a collaborative effort by the National Association of Certified Professional Midwives (NACPM), Midwives Alliance of North America (MANA), Citizens for Midwifery (CfM), Internation
(Date:12/4/2009)SAN FRANCISCO, Dec. 4 Medithrive, Inc. has won the Patient,s Choice Award as the favorite dispensary in the SF Bay Area by popular vote conducted by the online website, www.weedmaps.com. Despite on
(Date:12/4/2009)MADISON HEIGHTS, Mich., Dec. 4 The Editorial Advisory and Securities Review Committee of BetterInvesting Magazine today announced Allergan, Inc. (NYSE: AGN ) as its February 2010 "Stock to Stud
(Date:12/4/2009)STANFORD, Calif. A new study shows that muscle cells grown in the lab can restore an intestine,s ability to squeeze shut properly. The work, performed in dogs and rats, might ultimately help treat pa
Breaking Medicine News(10 mins):Health News:Advances in Genetic Understanding and Treatment Protocols Lead to Significant Progress in Leukemia and Myeloproliferative Disorders 2Health News:Advances in Genetic Understanding and Treatment Protocols Lead to Significant Progress in Leukemia and Myeloproliferative Disorders 3Health News:Advances in Genetic Understanding and Treatment Protocols Lead to Significant Progress in Leukemia and Myeloproliferative Disorders 4Health News:Advances in Genetic Understanding and Treatment Protocols Lead to Significant Progress in Leukemia and Myeloproliferative Disorders 5Health News:Advances in Genetic Understanding and Treatment Protocols Lead to Significant Progress in Leukemia and Myeloproliferative Disorders 6Health News:Advances in Genetic Understanding and Treatment Protocols Lead to Significant Progress in Leukemia and Myeloproliferative Disorders 7Health News:Advances in Genetic Understanding and Treatment Protocols Lead to Significant Progress in Leukemia and Myeloproliferative Disorders 8Health News:Advances in Genetic Understanding and Treatment Protocols Lead to Significant Progress in Leukemia and Myeloproliferative Disorders 9Health News:AquaNatal Birth Center Gives Away a Waterbirth Package to Celebrate the Successful MAMA Campaign 2Health News:AquaNatal Birth Center Gives Away a Waterbirth Package to Celebrate the Successful MAMA Campaign 3Health News:AquaNatal Birth Center Gives Away a Waterbirth Package to Celebrate the Successful MAMA Campaign 4Health News:BetterInvesting Magazine Releases February Stock to Study and Undervalued Stock Choicesfor Investors' Informational and Educational Use 2Health News:Muscle cell infusion shown to strengthen sphincters in animals in Stanford study 2Health News:Muscle cell infusion shown to strengthen sphincters in animals in Stanford study 3Health News:Muscle cell infusion shown to strengthen sphincters in animals in Stanford study 4
... , , , , Wheelock becomes chair, McNerney is v... EAGAN, Minn., Feb. 13 The Blue Cross and Blue Sh...as elected new board leaders. Pamela Wheelock, vic...cently held the position of vice chair. Wheelock h...
...nds even without weight loss, general health, func...thDay News) -- Even if it doesn,t help them lose w... quality of life, a U.S. study shows. , It include... expenditure of 4 kilocalories per kilogram (2.2 p...
...RTLAND, Oregon, Feb. 13 Women,s Healthcare Associ... midwifery, maternal fetal,medicine and genetics p... has,been honored by the American Academy of Nurse..., received the honor in a recent ceremony. America...
... - Dr. Tommy Tomizawa of UCLA Medical Center will ...cs may be beneficial to the elderly - , , TORRANC...ulation expected to climb over 300% in the next 50...mizawa, Assistant Professor at the David Geffen Me...
... highest ionized serum calcium 3 times more likely...(HealthDay News) -- A newly identified biomarker f... to decide whether or not to undergo treatment for...ith the lowest levels, said researchers at Wake Fo...
...E, Feb. 13 Seattle native composer Mateo Messina,... has recently won a Grammy award for Best Compilat... Other Visual Media. The team of talented artists ...es such as Juno and Thank You for Smoking to t...
Other Medicine News:Health News:Blue Cross Board of Trustees Elects New Leadership 2Health News:Exercise Boosts Quality of Life in Postmenopausal Women 2Health News:Women's Healthcare Associates Midwife Winner of American Academy of Nurse Practitioners State Award of Excellence 2Health News:The Effects of Probiotics on the Aging Digestive Tract to be Presented at Nutracon 2009 2Health News:Researchers ID Biomarker for Fatal Prostate Cancer 2Health News:Seattle Native Composer's Work Wins Grammy Award 2
...ratory and a worldwide leader in innovative labora...nsive test menu of highly complex and unique medic... by the University of Utah, ARUP Laboratories' cli...sity teaching hospitals and children's hospitals, ...
...ratory and a worldwide leader in innovative labora...nsive test menu of highly complex and unique medic... by the University of Utah, ARUP Laboratories' cli...sity teaching hospitals and children's hospitals, ...
...ratory and a worldwide leader in innovative labora...nsive test menu of highly complex and unique medic... by the University of Utah, ARUP Laboratories' cli...sity teaching hospitals and children's hospitals, ...
...ratory and a worldwide leader in innovative labora...nsive test menu of highly complex and unique medic... by the University of Utah, ARUP Laboratories' cli...sity teaching hospitals and children's hospitals, ...
Medicine Products: